Mical Paul

Mical Paul

Technion Israel Institute of Technology - Haifa / Israel
Medical and Health Sciences / Infectious Diseases
AD Scientific Index ID: 409492
הטכניון – מכון טכנולוגי לישראל
person_outline Mical Paul's MOST POPULAR ARTICLES
1-) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisE Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ...The Lancet Infectious Diseases 18 (3), 318-327, 201830612018
2-) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsisM Paul, V Shani, E Muchtar, G Kariv, E Robenshtok, L LeiboviciAntimicrobial agents and chemotherapy 54 (11), 4851-4863, 20107362010
3-) International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical …BT Tsuji, JM Pogue, AP Zavascki, M Paul, GL Daikos, A Forrest, ...Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (1 …, 20197662019
4-) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual …SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ...The lancet Respiratory medicine 2 (5), 395-404, 20147672014
5-) β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trialsM Paul, I Benuri-Silbiger, K Soares-Weiser, L LeiboviciBmj 328 (7441), 668, 20046222004